The AI engine is offline (last seen Aug 12, 05:02 UTC). Scores are shown as of their timestamps; new theses and refreshes are queued and run the moment it returns.

Macro

Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.

Home tech energy finance healthcare defense industrial consumer communication utilities real estate raw materials
← back
healthcare · sector mood
2015
year mood +0.29 · -0.20 to +0.50 across 12 mo
Monthly mood
bearish −1 +1 bullish
-0.5 -0.25 0 +0.25 +0.5 Jan Feb +0.50 Mar Apr May Jun Jul Aug Sep Oct Nov -0.20 Dec
month values ▾
JanFebMarAprMayJunJulAugSepOctNovDec
+0.40+0.50+0.50+0.50+0.50+0.50+0.50+0.30+0.00+0.00-0.20+0.00

Healthcare and biotech peaked mid-year, but September's Shkreli price-gouging scandal and Hillary Clinton's 'outrageous' price-gouging tweet triggered a political firestorm that crashed biotech and made drug pricing THE issue; a sharp inflection down.

How this mood is scored ▾
Each day the model reads that day's news for the sector and asks, as someone who owns assets or makes their living in it: how am I feeling this month, and why? The month's mood is that running answer, tied to the specific events driving it (the story shown above). It leans on trusted, higher-impact reporting, and on the prior month when a month is quiet, so one loud headline can't swing it. The read updates daily through the month; once a month ends, its mood is locked. This year is read live from the news the pipeline actually collected (hover a bar for its story count). · last computed Jul 06, 2026
Top healthcare stories of 2015
Nov
Pfizer, Allergan to Merge in $160B Pharma Deal cbc.ca →

Pfizer and Allergan announced a $160 billion reverse merger, structured to lower Pfizer's tax burden by relocating its domicile to Ireland via Allergan. The deal combines Pfizer’s global drug portfolio with Allergan’s specialty brands, creating the world’s largest pharmaceutical company. The move underscores ongoing corporate tax inversion trends, drawing scrutiny amid weak U.S. regulatory enforcement.